Why does Pharma Need to Relook at its Patient Engagement and Support Strategies?

Why does Pharma Need to Relook at its Patient Engagement and Support Strategies?

Recently, I was reading Luca Dezzani’s article “Patient Engagement: A Key Element in Pharmaceutical Marketing Strategy.” The article prompted me to think about how pharma companies continue to think about and discuss the idea of Patient Engagement, and.... Read More »

Building Regulatory Affairs: Efficiency Quadrant that Drives Spend

Building Regulatory Affairs: Efficiency Quadrant that Drives Spend

Best Practices, LLC has recently completed “Benchmarking Regulatory Affairs Staffing & Performance Excellence in Medical Devices,” a new operational benchmarking study. After analyzing the data and probing the experience of 30 regulatory affairs (RA).... Read More »

Blockbuster Launch Evolution: Learning to See the Market in Different Wavelengths and Perspectives (Part 2)

Blockbuster Launch Evolution: Learning to See the Market in Different Wavelengths and Perspectives (Part 2)

One of the areas within the Pharmaceutical and related industries which has the main goal of seeing market opportunities is the Market Research function. Despite this, many organizations’ Market Research groups do not have 20/20 vision. Read More »

New Series: Blockbuster Pharmaceutical Drugs Launch Evolution (Part-1)

New Series: Blockbuster Pharmaceutical Drugs Launch Evolution (Part-1)

At Pharma CI Conference 2015 in New Jersey, Best Practices, LLC’s CEO, Chris Bogan discussed the topic: Blockbuster Drugs Launch Evolution: Mapping Market - Entry Changes That Cause New Products to Stumble or Soar.... Read More »

Relationships Matter: To be Effective, Medical Information Groups in Pharmaceutical Companies Must Forge Collaborative Relationships with other Internal Groups such as Legal

Relationships Matter: To be Effective, Medical Information Groups in Pharmaceutical Companies Must Forge Collaborative Relationships with other Internal Groups such as Legal

Within the pharmaceutical sector, medical information groups shoulder great responsibilities. The principal role of medical information groups, which are typically part of the medical affairs organization, is responding to questions about products from external groups such as physicians. Read More »

Achieving Better Advocacy Group Relationships a Critical Piece of Resurgent Disease State Awareness Drive in Pharmaceutical Industry

Achieving Better Advocacy Group Relationships a Critical Piece of Resurgent Disease State Awareness Drive in Pharmaceutical Industry

When it comes to informing physicians and patients about new therapies, disease awareness programs have experienced a rebirth in the pharmaceutical industry. Read More »

How Can Pharma Leverage the Health Outcomes Liaison Function for Maximum Impact?

How Can Pharma Leverage the Health Outcomes Liaison Function for Maximum Impact?

With the shift toward evidence-based medicine and value-based pricing in the health care industry, bio-pharmaceutical organizations have turned to Health Outcomes Liaisons (HOLs) to serve as a scientific bridge with payer organizations, thought leaders, and other important decision makers. Read More »

Brand Lifecycle Management: Strategies for Every Budget

Brand Lifecycle Management: Strategies for Every Budget

Many pharmaceutical companies use strategies to extend the commercial life of mature pharmaceutical brands and minimize market share decline, but Best Practices LLC and RxSolutions have identified superior strategies across different investment levels from survey results of 25 executives representing 18 companies. Read More »

Apple & Amazon Have Entered Healthcare: How Will Medical Affairs Work with Large Employers?

Apple & Amazon Have Entered Healthcare: How Will Medical Affairs Work with Large Employers?

Apple’s announcement that it will begin providing healthcare to its employees and families offers one more reason that Medical Affairs groups should ramp up their efforts to work with Large Employer groups. Read More »

 

One Way to Please the Boss (& the Boss’s Boss): Crafting Highly Effective Executive Briefs

A quick peek behind the curtain at the Best Practices Research Center and a Most Interesting Case that recently landed on my desk. We are a consulting firm whose clients work mainly in the pharma and biotech sector.  As a

Exclusive: Key Findings from Best Practices’ 5th Medical Affairs Consortium

Author:

Best Practices recently completed the second roundtable of our 2014-2015 Medical Affairs Consortium. The roundtable addressed the topic of “Medical Affairs Launch Support.” The roundtable brought together executives from 13 leading pharmaceutical organizations. Some exclusive key findings from the discussion

Google Life Sciences Making Strides to Get Under Our Skin (for Good Reasons)

Six months ago, I wrote a blog about how Google and Apple were pushing into the healthcare industry with their innovative apps – Google’s and Alcon Labs’ “smart” contact lens and Apple’s foray into new health apps that track everything

Patient Centricity Has Arrived. Bigger Question: Where Is It Headed?

Patients have always been on pharma’s radar, though it has historically been as a target of marketing (the most obvious being Direct to Consumer (DTC) advertising).  But now under the banner of Patient Centricity, pharma companies large and small are

Six Digital Marketing Trends that will Affect the Pharmaceutical Industry in 2015

The pharma sector has long trailed more consumer and tech-savvy industries in the uptake of digital media for marketing their products. Uncertainty around industry regulations and how to safely interact with patients and physicians have prevented many large pharma organizations

Top Trends in 2015 – Is Your Organization Prepared?

Author:

2015 is here & with the New Year comes many new trends and topics of discussion. With the increasing importance of payers and high demand on evidence-based information, it is clear that there are many shifts happening in the pharmaceutical,

Internal Communication Commandments to Live By

In order to improve an organization as a whole, it is critical to improve internal corporate communications. Best Practices, LLC’s work highlights how companies deliver their internal messages and find the proper balance between informing and educating employees. We have seen companies

Best Practices in Lifecycle Management: Maximizing the Potential of Mature Brands

Author:

As many drugs are reaching the patent cliff, strategies to extend the commercial life of mature brands is critical to today’s pharmaceutical industry. Used correctly, lifecycle management strategies can add as many as 10 years and billions of dollars to

Medical Affairs Consortium: Impact Measures, Globalization & Compliance

Author:

On November 6, 2014 Best Practices, LLC hosted the 1st roundtable of the 2014-2015 Medical Affairs’ Consortium. The roundtable brought together leaders from: Baxter, Crescendo, Eli Lilly, Genentech, Incyte Corporation, Jazz Pharmaceuticals, Pfizer, Santen Inc., Teva, and Upsher-Smith. Leaders from

How To: Stop “No” From Being a 4-Letter Word

Not too long ago, a colleague jokingly compared me to a consigliere. (Think Marlon Brando in “The Godfather”). He said he didn’t know how I got any work done, as people wander in and out of my office to speak

5 Things Pharma Professionals Need to Know About Big Data

Big Data has its roots in a set of statistical methods called econometrics A main feature of the finance, biology, and the social sciences is the apparent randomness of the behaviors being measured. Econometrics exists to distill the random and

Best Practices’ Hosting Medical Affairs Consortium Roundtable Thursday, Nov. 6

Author:

Best Practices designed the Medical Affairs Consortium to provide Medical Affairs leaders with a forum for sharing insights about the key challenges they face. The consortium has developed a mechanism for creating and sharing solutions through three virtual roundtable discussions

Big Data in Pharma: What is Big Data?

We are past the peak of the Big Data hypecycle, not least of all because about half of the content on the topic put out by marketing gurus, branding experts, and other non-practitioners has moved on from extolling Big Data

Pharma Companies Feeling the Heat From the Sunshine Act

Author:

Last week marked the release of the initial data from the Sunshine Act law of the Affordable Care Act, which had been dreaded by many health care professionals and pharmaceutical and medical device executives. So, for the past few years,